Irradiation of mammalian cells can cause cell cycle perturbations and
apoptotic cell death. We have investigated the modulation of these phy
siologic end points by growth factor stimulation: irradiation of a mur
ine hematopoietic cell line in the presence of interlekin-3 (IL-3) ind
uces G(1) arrest, and irradiation in the absence of IL-3 results in ra
pid apoptotic cell death. Both of these end points are dependent on p5
3. Transient removal of IL-3 at the time of irradiation results in dec
reased clonogenic survival of irradiated cells. The removal of IL-3 re
sults in a failure of the irradiated cells to arrest at the G(1) check
point, despite induction of p53 and p21(WAF1/CIP1), and then the cells
enter S-phase where they undergo apoptosis. There are no cytokine-rel
ated changes in Bcl-2, Bax, or Bcl-x protein levels that could account
for the modulation of G(1) arrest versus apoptosis by growth factors.
In contrast, rapid p53-independent alterations of basal levels of gad
d45 and p21(WAF1/CIP1) expression are linked to IL-3 withdrawal, sugge
sting a potential mechanism for this modulation. Constitutive activati
on of cytokine-like pathways with induced expression of v-Src or activ
ated c-Raf inhibits the radiation-induced apoptosis and the alteration
s in p21(WAF1/CIP1) and gadd45 expression. These observations suggest
additional molecular mechanisms that can contribute to the development
of radioresistance and resistance to apoptosis during tumorigenesis a
nd provide an explanation for the observed lack of p53 mutations in so
me tumor types. In addition, these data suggest that oncogenic changes
occurring during multistep tumorigenesis could be classified as those
that either enhance or decrease apoptosis tendencies.